Functional Neuromodulation Ltd. is investigating the use of deep brain stimulation of the fornix (DBS-f) to drive neural activity and modulate the brain’s memory circuit. The company completed a Phase II multi-center clinical trial of DBS-f in 42 patients with mild probable Alzheimer’s. Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of people with mild Alzheimer’s disease. CAUTION — Investigational device. Limited by Federal law to investigational use
View Top Employees from Functional Neuromodulation| Website | http://www.fxneuromod.com |
| Employees | 4 (3 on RocketReach) |
| Founded | 2011 |
| Technologies |
JavaScript,
PHP,
Google Analytics
+2 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Therapeutic Devices, Biotechnology |
| Web Rank | 24 Million |
| Keywords | Functional Neuromodulation |
Looking for a particular Functional Neuromodulation employee's phone or email?
Functional Neuromodulation Questions
Lisa Fosdick is the Vice President Global Clinical Operations of Functional Neuromodulation.
3 people are employed at Functional Neuromodulation.
Top Functional Neuromodulation Employees
-
ViewKristen Drake
VP CLINICAL & REGULATORY AFFAIRS/Consultant at Functional Neuromodulation
Coppell, Texas, United States25+
Related Companies
